Novo Nordisk A/SNVONYSE
Loading
Year-over-year debt growth rate
5Y CAGR
-29.1%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 27.41% |
| 2024 | 280.61% |
| 2023 | 4.74% |
| 2022 | -3.23% |
| 2021 | 1465.23% |
| 2020 | 152.78% |
| 2019 | 30.76% |
| 2018 | -69.60% |
| 2017 | 639.74% |
| 2016 | -78.66% |